These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3964298)

  • 1. A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductase.
    Drake JC; Allegra CJ; Chabner BA
    Biochem Pharmacol; 1986 Apr; 35(7):1212-4. PubMed ID: 3964298
    [No Abstract]   [Full Text] [Related]  

  • 2. An isotopic assay for dihydrofolate reductase.
    Roberts D
    Biochemistry; 1966 Nov; 5(11):3549-51. PubMed ID: 4382039
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of methotrexate, folates, and pyridine nucleotides with dihydrofolate reductase: calorimetric and spectroscopic binding studies.
    Subramanian S; Kaufman BT
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3201-5. PubMed ID: 28523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive protein binding assay for methotrexate.
    Myers CE; Lippman ME; Elliot HM; Chabner BA
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3683-6. PubMed ID: 810804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic study of the influence of NADPH on the binding of methotrexate and its metabolites to a mammalian dihydrofolate reductase.
    Gilli RM; Sari JC; Sica LM; Briand CM
    Biochim Biophys Acta; 1988 Jan; 964(1):53-60. PubMed ID: 3334873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase from a methotrexate-resistant Escherichia coli.
    Poe M; Greenfield NJ; Williams MN
    J Biol Chem; 1974 May; 249(9):2710-6. PubMed ID: 4151306
    [No Abstract]   [Full Text] [Related]  

  • 9. A 13C nuclear magnetic resonance study of the interaction of ligands with arginine residues in dihydrofolate reductase.
    Cocco L; Blakley RL; Walker TE; London RE; Matwiyoff NA
    Biochem Biophys Res Commun; 1977 May; 76(1):183-8. PubMed ID: 17403
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate.
    Matthews DA; Alden RA; Bolin JT; Freer ST; Hamlin R; Xuong N; Kraut J; Poe M; Williams M; Hoogsteen K
    Science; 1977 Jul; 197(4302):452-5. PubMed ID: 17920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate binding to dihydrofolate reductase.
    Roberts GC; Feeney J; Birdsall B; Charlton P; Young D
    Nature; 1980 Jul; 286(5770):309. PubMed ID: 7402318
    [No Abstract]   [Full Text] [Related]  

  • 14. Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):645-9. PubMed ID: 6952216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate.
    Schlegel HB; Poe M; Hoogsteen K
    Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022
    [No Abstract]   [Full Text] [Related]  

  • 17. Light activates reduction of methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate reductase.
    Chen YQ; Gulotta M; Cheung HT; Callender R
    Photochem Photobiol; 1999 Jan; 69(1):77-85. PubMed ID: 10063803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of ligand binding to dihydrofolate reductase: binary complex formation with NADPH and coenzyme analogues.
    Dunn SM; Batchelor JG; King RW
    Biochemistry; 1978 Jun; 17(12):2356-64. PubMed ID: 28144
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
    Allegra CJ; Boarman D
    Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadditivity of mutational effects at the folate binding site of Escherichia coli dihydrofolate reductase.
    Huang Z; Wagner CR; Benkovic SJ
    Biochemistry; 1994 Sep; 33(38):11576-85. PubMed ID: 7918371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.